These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34172714)

  • 1. Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Itami M; Hippo Y
    Oncogenesis; 2021 Jun; 10(6):46. PubMed ID: 34172714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
    J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
    Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y
    Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide CRISPR Screen to Identify Genes that Suppress Transformation in the Presence of Endogenous Kras
    Huang J; Chen M; Xu ES; Luo L; Ma Y; Huang W; Floyd W; Klann TS; Kim SY; Gersbach CA; Cardona DM; Kirsch DG
    Sci Rep; 2019 Nov; 9(1):17220. PubMed ID: 31748650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells.
    Dost AFM; Moye AL; Vedaie M; Tran LM; Fung E; Heinze D; Villacorta-Martin C; Huang J; Hekman R; Kwan JH; Blum BC; Louie SM; Rowbotham SP; Sainz de Aja J; Piper ME; Bhetariya PJ; Bronson RT; Emili A; Mostoslavsky G; Fishbein GA; Wallace WD; Krysan K; Dubinett SM; Yanagawa J; Kotton DN; Kim CF
    Cell Stem Cell; 2020 Oct; 27(4):663-678.e8. PubMed ID: 32891189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
    Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
    Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer.
    Schiavone M; Rampazzo E; Casari A; Battilana G; Persano L; Moro E; Liu S; Leach SD; Tiso N; Argenton F
    Dis Model Mech; 2014 Jul; 7(7):883-94. PubMed ID: 24878567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
    Zhang L; Ma T; Brozick J; Babalola K; Budiu R; Tseng G; Vlad AM
    Oncogene; 2016 Sep; 35(38):5010-20. PubMed ID: 26973247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal tumor cells drive adaptive resistance of Trp53
    van Weele LJ; Djomehri SI; Cai S; Antony J; Sikandar SS; Qian D; Ho WHD; West RB; Scheeren FA; Clarke MF
    Mol Oncol; 2022 Sep; 16(17):3128-3145. PubMed ID: 35398967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
    Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
    PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
    Yamasaki J; Hirata Y; Otsuki Y; Suina K; Saito Y; Masuda K; Okazaki S; Ishimoto T; Saya H; Nagano O
    Cancer Sci; 2022 Mar; 113(3):916-925. PubMed ID: 34931404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture.
    Li X; Nadauld L; Ootani A; Corney DC; Pai RK; Gevaert O; Cantrell MA; Rack PG; Neal JT; Chan CW; Yeung T; Gong X; Yuan J; Wilhelmy J; Robine S; Attardi LD; Plevritis SK; Hung KE; Chen CZ; Ji HP; Kuo CJ
    Nat Med; 2014 Jul; 20(7):769-77. PubMed ID: 24859528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers.
    Cheng R; Li F; Zhang M; Xia X; Wu J; Gao X; Zhou H; Zhang Z; Huang N; Yang X; Zhang Y; Shen S; Kang T; Liu Z; Xiao F; Yao H; Xu J; Yan C; Zhang N
    Cell Res; 2023 Jan; 33(1):30-45. PubMed ID: 36241718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.
    Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER
    Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
    Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H
    J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETRACTED: KRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis.
    Yoon C; Till J; Cho SJ; Chang KK; Lin JX; Huang CM; Ryeom S; Yoon SS
    Mol Cancer Res; 2019 Sep; 17(9):1945-1957. PubMed ID: 31217166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.